 |
|
|
|
|
|
|
The next generation dual-assay analyzer for the quantiation of HbA1c and Hb variants, the ultra2 delivers fast and accurate measurements of patient glycohemoglobin levels and aids in the comprehensive identification and quantiation of hemoglobin variants.
The ultra2 is engineered to provide superior accuracy, speed, precision, results.
Hb Variant Assay
The ultra2 Resolution platform offers breakthrough technology for the detection of hemoglobin variants. Featuring the fastest available (4 minute) Hb Screen with A2 and F quantitation, this system is the only system on the market to automatically reflex from Quick Scan to a 10-minute High Resolution program for further Hb variant characterization and quantitation. Unequaled quality of peak separation utilizing HPLC technology, plus continuously updated computer aids to assist in accurate interpretation of results. Additional features include the option to use automated sample prep from the primary whole blood tube or manual hemolysates or blood spots, plus on-line bar-code reading, simple menu-driven software, and LIS interface.
Hb Variant Newborn Screening
The ultra2 Resolution platform has a new HPLC assay for the detection of hemoglobin variants in newborns. It will identify F, A and clinically significant variants S, C, D, E, O and Bart’s and many more. This system features a 2 minute Hb Screen with an automatic transition to a confirmatory method for samples with Hb variants without user intervention. The automation of sample preparation to sample reporting makes the ultra2 a convenient and fast analytical tool for today’s busy laboratories.
 |
|
|
|
 |
|
||
 |
 |
 |
|
 |
|
||
 |
|
||
 |
|
||
 |
|
||
 |
 |
||
 |
|
||
 |
|
||
 |
|
||